vatalanib has been researched along with Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachelier, R; Clézardin, P; Confavreux, CB; Croset, M; Goehrig, D; Peyruchaud, O; van der Pluijm, G | 1 |
| Brasch, RC; Carter, WO; Floyd, E; Fu, Y; Novikov, V; Preda, A; Roberts, TP; Shames, DM; Turetschek, K; Wood, JM | 1 |
| Huang, S; Kim, LS; Lev, DC; Lu, W; Price, JE | 1 |
3 other study(ies) available for vatalanib and Breast Cancer
| Article | Year |
|---|---|
Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunocompromised Host; Mice; Mice, Inbred C3H; Osteolysis; Phthalazines; Pregnancy; Pyridines; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Endothelium, Vascular; Female; Humans; Magnetic Resonance Imaging; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Predictive Value of Tests; Pyridines; Rats; Treatment Outcome | 2003 |
Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice.
Topics: Animals; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal; Carotid Artery, Internal; Cell Hypoxia; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Injections, Intra-Arterial; Interleukin-8; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Pyridines; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2004 |